Impact of cancer cachexia on the therapeutic outcome of combined chemoimmunotherapy in patients with non-small cell lung cancer: a retrospective study

Although previous studies suggest that cancer cachexia is a poor prognostic factor for immune checkpoint inhibitor monotherapy, the impact of cancer cachexia on chemoimmunotherapy is unclear. We investigated the impact of cancer cachexia on the therapeutic outcomes of chemoimmunotherapy for non-smal...

Descripción completa

Detalles Bibliográficos
Autores principales: Morimoto, Kenji, Uchino, Junji, Yokoi, Takashi, Kijima, Takashi, Goto, Yasuhiro, Nakao, Akira, Hibino, Makoto, Takeda, Takayuki, Yamaguchi, Hiroyuki, Takumi, Chieko, Takeshita, Masafumi, Chihara, Yusuke, Yamada, Takahiro, Hiranuma, Osamu, Morimoto, Yoshie, Iwasaku, Masahiro, Kaneko, Yoshiko, Yamada, Tadaaki, Takayama, Koichi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Taylor & Francis 2021
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8274442/
https://www.ncbi.nlm.nih.gov/pubmed/34290909
http://dx.doi.org/10.1080/2162402X.2021.1950411

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8274442/
https://www.ncbi.nlm.nih.gov/pubmed/34290909
http://dx.doi.org/10.1080/2162402X.2021.1950411

Ejemplares similares